National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 1045495

History of Changes from the VAERS Wayback Machine

First Appeared on 6/4/2021

VAERS ID: 1045495
VAERS Form:2
Vaccin­ation / Manu­facturer Lot / Dose Site / Route

Administered by: Other      Purchased by: ??
Symptoms: Blood sodium, Fatigue, Hypernatraemia, General physical health deterioration

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died:0000-00-00
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: ELIQUIS
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Cardiac failure; Cognitive impairment; Fibrillation cardiac NOS; Multimorbidity
Diagnostic Lab Data: Test Date: 202101; Test Name: blood sodium; Result Unstructured Data: Test Result:153
CDC 'Split Type': SEPFIZER INC2021158459

Write-up: Hypernatremia; Reduced general condition; more tired; This is a spontaneous report from a contactable physician downloaded from the regulatory authority-WEB, Regulatory Authority number SE-MPA-2021-002838. Other case identifier number SE-MPA-1612528958083. A 91-year-old female patient received second dose of bnt162b2 (COMIRNATY, lot# EJ6795) via an unspecified route of administration in Jan2021 at single dose for COVID-19 immunisation. Medical history included multimorbidity, fibrillation cardiac NOS, cardiac failure, cognitive impairment. The patient had been walking shorter distances with a walker. Concomitant medication included apixaban (ELIQUIS). No previous drug reactions. The day after the patient received dose 2 of the vaccination, she became more tired and was bedridden. Ate and drank were ok. Vital parameters were stable. Nine days after vaccination, lab of Na was 153, otherwise essentially were ok. The patient developed reduced general condition and hypernatremia in Jan2021. The patient became increasingly tired and died quietly about 2 weeks after the vaccination with bnt162b2. Cause of death was reduced general condition and hypernatremia. It was not reported if an autopsy was performed. The outcome of event fatigue was unknown, outcome of events reduced general condition and hypernatremia was fatal. No follow-up attempts possible. No further information expected.; Reported Cause(s) of Death: Reduced general condition; Hypernatremia

New Search

Link To This Search Result:

Government Disclaimer on use of this data

Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166